Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: Prevention and Treatment of Illicit Substance Use

Centre for Addiction and Mental Health (Toronto)

$100,000.00

Effects of Fixed or Self-Titrated dosages of Sativex® on Cannabis Users

EF 2010-11

Résumé
Cannabis (marijuana) is one of the most widely used psychoactive substances in the world. Cannabis dependence is currently regarded as affecting around 10% of those ever exposed to cannabis. Current psychological treatments for cannabis dependence have been proven to be only mildly effective and there is no pharmacological treatment for cannabis dependence today. Most effective medical treatments for addictions are currently based on substitution medication (for example, nicotine replacement therapy for cigarette smokers). Sativex is a drug based on substances derived from the marijuana plant. As Sativex contains the two main substances that are present in cannabis, it may be the ideal substitution therapy in cannabis users. Here, a team of researchers with complementary expertise will explore the possibility of using Sativex in treatment of cannabis users. This preliminary study may lead to a novel treatment for cannabis dependence.
Programme
Catalyst Grant: Prevention and Treatment of Illicit Substance Use
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
223025
Name
Le Foll Bernard
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Catalyst Grant: Prevention and Treatment of Illicit Substance Use
Projecttitle
Effects of Fixed or Self-Titrated dosages of Sativex® on Cannabis Users
Programtype2
Operating Grants
Orgnameinp2
Centre for Addiction and Mental Health (Toronto)
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Prevention and Treatment of Illicit Substance Use
Keyworddelim
Cannabidiol; Cannabis; Cannabis Withdrawal; Dependence; Preliminary; Sativex; Tetrahydrocannabinol; Withdrawal
Abstract
Cannabis (marijuana) is one of the most widely used psychoactive substances in the world. Cannabis dependence is currently regarded as affecting around 10% of those ever exposed to cannabis. Current psychological treatments for cannabis dependence have been proven to be only mildly effective and there is no pharmacological treatment for cannabis dependence today. Most effective medical treatments for addictions are currently based on substitution medication (for example, nicotine replacement therapy for cigarette smokers). Sativex is a drug based on substances derived from the marijuana plant. As Sativex contains the two main substances that are present in cannabis, it may be the ideal substitution therapy in cannabis users. Here, a team of researchers with complementary expertise will explore the possibility of using Sativex in treatment of cannabis users. This preliminary study may lead to a novel treatment for cannabis dependence.
Competitiondate
201101
Approvedterm2
1 yr 0 mth
Pinamesdelim
Le Foll, Bernard
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Neurosc Mental Hlth &A~ $100,000~ $0~